Figures computed from official regulatory filings — .
Ownershipinsiders 88.68% · institutions 0%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Mosaic ImmunoEngineering Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. The company engages in pursuing new product candidates and platforms to build a pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
46 buys34 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Steinmetz Nicole Franziska | OtherD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC |
| KING STEVEN W | OtherD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC |
| FELCYN GLORIAtrack record | OtherD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC |
| GARNICK ROBERT L | OtherD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC |
| BAFFI ROBERTtrack record | OtherD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC |
| FELCYN GLORIAtrack record | OtherD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC |
| GARNICK ROBERT L | OtherD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC |
| Steinmetz Nicole Franziska | AwardD (derivative) | $15K | SEC |
| Steinmetz Nicole Franziska | Other | n/a (No price was disclosed in the filing) | SEC |
| Steinmetz Nicole Franziska | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Steinmetz Nicole Franziska | Other | n/a (No price was disclosed in the filing) | SEC |
| KING STEVEN W | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Steinmetz Nicole Franziska | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| LYTLE PAUL J | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| LYTLE PAUL J | Other | n/a (No price was disclosed in the filing) | SEC |
| GARNICK ROBERT L | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| KING STEVEN W | Other | n/a (No price was disclosed in the filing) | SEC |
| GARNICK ROBERT L | Other | n/a (No price was disclosed in the filing) | SEC |
| FELCYN GLORIAtrack record | AwardD (derivative) | $86.1K | Unusual size | SEC |
| LYTLE PAUL J | AwardD (derivative) | $124.6K | SEC |
| LYTLE PAUL J | AwardD (derivative) | $139.9K | SEC |
| KING STEVEN W | AwardD (derivative) | $215.2K | SEC |
| JOHNSON CARLTON Mtrack record | AwardD (derivative) | $86.1K | SEC |
| KING STEVEN W | AwardD (derivative) | $143.5K | SEC |
| GARNICK ROBERT L | AwardD (derivative) | $86.1K | SEC |